Benzinga | Jan 6, 2021 07:24AM EST

Cowen & Co. Upgrades Amyris to Outperform, Announces $9 Price Target

Cowen & Co. analyst Doug Schenkel upgrades Amyris (NASDAQ:AMRS) from Market Perform to Outperform and announces $9 price target.